Multitarget therapeutic potential of sulforaphane in ethidium bromide-induced neurotoxicity in multiple sclerosis-like pathology: comparison with omaveloxolone and dimethyl fumarate on neuroprotection and systemic recovery

Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by demyelination, neuroinflammation, and neurodegeneration. This study investigates the neuroprotective potential of Sulforaphane